C20-D3-retinyl acetate April 12, 2017 C20-D3-retinyl acetate Trade Name Orphan Indication Stargardt's disease USA Market Approval USA USA Designation Date 2010-09-16 00:00:00 Sponsor Alkeus pharmaceuticals, Inc.;2103 Massachusetts Avenue;Cambridge, Massachusetts, 02140
